On November 4, 2009
Amateur Hour at Merck: FDA Refuses to Look at Zetia-Lipitor Combo Pill
Merck was sent back to the drawing board on its new Zetia-Lipitor combo drug when the FDA refused to accept its application. That’s an unheard of gaffe for a Big Pharma firm. Merck slipped the news into its 10-Q filing with the SEC.
0 Comments